Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population

Medicine (United States)

Volumn 68, Issue 3, 1989, Pages 141-150

  Jonsson, Helgi ^a   Nived, Ola ^a   Sturfelt, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ETHNIC OR RACIAL ASPECTS; HUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SKIN DISEASES; SUPPORT, NON-U.S. GOV'T; SWEDEN;

EID: 0024510595     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-198905000-00002     Document Type: Article

References (50)

1. Aarden LA, DeGroot ER, Feltkamp TEW. Crithidia luciiiae, a simple substrate for the determination of anti ds-DNA with immunofluorescence technique. Ann NY Acad Sci 254: 504-515, 1975.
2. Ahlbom A. Acute myocardial infarction in Stockholm-A medical information system as an epidemiological tool. Int J Epidemiol 7: 271-276, 1978.
3. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 83: 877-885, 1987.
4. Ball J. Serum factor in rheumatoid arthritis agglutinating sensitized sheep cells. Lancet 2: 520-524, 1950.
5. Bell DA. Editorial: SLE in the elderly-Is it really SLE or systemic Sjogren's syndrome. J Rheumatol 15: 723-724, 1988.
6. Bell DA, Rigby R, Stiller CR, Clark WF, Harth M, Ebers G. HLA antigens in systemic lupus erythematosus: Relationship to disease severity, age at onset, and sex. J Rheumatol 11: 475-479, 1984.
7. Berglund E, Birath G, Bjure J, Grimby G, Kjellmer I, Sandquist L, Soderholm B. Spirometrie studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 173: 185-192, 1963.
8. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69: 849-858, 1980.
9. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 58: 243-264, 1975.
10. Catoggio LJ, Skinner RP, Smith G, Maddison PJ. Systemic lupus erythematosus in the elderly: Clinical and serological characteristics. J Rheumatol 11: 175-181, 1984.
11. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50: 85-95, 1971.
12. Fries JF, Holman HR. Systemic lupus erythematosus. A clinical analysis. In: Smith LH Jr, ed. Major Problems in Internal Medicine. Vol. VI. Philadelphia: WB Saunders Co, 1976.
13. Fukumoto S, Tsumagari T, Kinjo M, Tanaka K. Coronary atherosclerosis in patients with systemic lupus erythematosus at autopsy. Acta Pathol Jpn 37: 1-9, 1987.
14. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum 25: 601-611, 1982.
15. Grigor RR, Shervington PC, Hughes GRV, Hawkins DF. Outcome of pregnancy in systemic lupus erythematosus. Proc Roy Soc Med 70: 99-100, 1977.
16. Grigor RR, Edmonds J, Lewkonia R, Bresnihan B, Hughes GRV. Systemic lupus erythematosus: A prospective analysis. Ann Rheum Dis 37: 121-128, 1978.
17. Gustafson I, Johansson G. Statistikinformation. Matematiska byrån. Riksforsäkringsverket, Stockholm 1983.
18. Halberg P, Alsbjbrn B, Trolle Balslev J, Lorenzen I, Gerstoft J, Ullman S, Wiik A. Systemic lupus erythematosus: Follow-up study of 148 patients. I: Classification, clinical and laboratory findings, course and outcome. Clinical Rheumatology I: 13-21, 1987.
19. Halberg P, Alsbjom B, Trolle Balslev J, Lorenzen I, Gerstoft J, Ullman S, Wiik A. Systemic lupus erythematosus: Follow-up study of 148 patients. II: Predictive factors of importance for course and outcome. Clinical Rheumatology I: 22-26, 1987.
20. Harris EN, Gharavi AE, Asherson RA, Brey ML, Hughes GRV. Cerebral infarction in systemic lupus: Association with anticardiolipin antibodies. Clin Exp Rheumatol 2: 47-51, 1984.
21. Hochberg MC, Boyd RE, Ahearn JM, Arnett FC, Bias WB, Provost TT, Stevens MB. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 64: 285-295, 1985.
22. Hochberg MC, Dorsch CA, Feinglass EJ, Stevens MB. Survivorship in systemic lupus erythematosus: Effect of antibody to extractable nuclear antigen. Arthritis Rheum 24: 54-59, 1981.
23. Hochberg MC, Sutton JD. Physical disability and psychosocial dysfunction in systemic lupus erythematosus. J Rheumatol 15: 959-964, 1988.
24. Jonsson H, Nived O, Sturfelt G, Norberg R. Symptomatic Sjogren's syndrome in patients with systemic lupus erythematosus (SLE): Relation to SS-A and SS-B autoantibodies. Scand J Rheumatol (Suppl 61): 166-169, 1987.
25. Jonsson H, Nived O, Sturfelt G. The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol 15: 505-509, 1988.
26. Lee P, Urowitz MB, Bookman AAM, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 46: 1-32, 1977.
27. Lightfoot RW, Hughes GRV. Significance of persisting serologic abnormalities in SLE. Arthritis Rheum 19: 837-843, 1976.
28. Lloyd W, Schur PH. Immune complexes, complement, and Anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine (Baltimore) 60: 208-217, 1981.
29. Maddison PJ, Provost TT, Reichlin M. Serologic findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) 60: 87-94, 1981.
30. Von Maur K, Turk A, Stevens MB, Adkinson NF Jr, Lichtenstein LM. Penicillin hypersensitivity in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 49: 428-433, 1975.
31. Merrell M, Schulman LE. Determination of prognosis in chronic disease illustrated by systemic lupus erythematosus. J Chron Dis I: 12-32, 1955.
32. Miller MH, Urowitz MB, Gladman DD, Killinger DW. Systemic lupus erythematosus in males. Medicine (Baltimore) 62: 327-334, 1983.
33. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus in an adult population in southern Sweden: Incidence, prevalence and validity of ARA revised classification criteria. Br J Rheumatol 24: 147-154, 1985.
34. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: A controlled study including an epidemiological group. Q J Med. New series 55: 271-287, 1985.
35. Rosner S, Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess V, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV. A multicenter study of outcome in systemic lupus erythematosus. Ü. Causes of death. Arthritis Rheum 25: 612-617, 1982.
36. Schein PS, Winokur SH. Immunosuppressive and cytotoxic chemotherapy: Long-term complications. Ann Intern Med 82: 84-95, 1975.
37. Sharp GC, Irvin WS, Tan EM. Mixed connective tissue disease, an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52: 148-159, 1972.
38. Siegel S. Non-parametric statistics for the behavioral sciences. Tokyo: McGraw-Hill Kogakusha Ltd, 1956.
39. Sjoholm AG. Complement components in normal serum and plasma quantitated by electroimmunoassay. Scand J Immunol 4: 25-30, 1975.
40. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 115: 1409-1415, 1979.
41. Statistisk årsbok. Statistical abstract of Sweden 1986.
42. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659-62, 1949.
43. Sturfelt G, Nived O. Clinical inconsistency, benign course and normal employment rates in unselected systemic lupus erythematosus. Clin Exp Rheumatol 3: 303-310, 1985.
44. Sturfelt G, Nived O, Norberg R, Thorstensson R, Krook K. Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 30: 1-7, 1987.
45. Sturfelt G, Sjbliolm AG. Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int Archs Allergy Appl Immunol 75: 75-83, 1984.
46. Swaak AJG, Aarden LA, Statius van Eps LW, Feltkamp TEW. Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22: 226-235, 1979.
47. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ, The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-1277, 1982.
48. Urowitz MB, Bookman AAM, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 60: 221-225, 1976.
49. Wallace DJ, Podell TE, Weiner J, Cox MB, Klinenberg JR, Forouzesh S, Dubois EL. Lupus nephritis: Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 72: 209-220, 1982.
50. Walravens PA, Chase P. The prognosis of childhood systemic lupus erythematosus. Am J Dis Child 130: 929-933, 1976.